M.J. Welsh and A.E. Smith, RAC Application 
14. Hubbard, R. C., N. G. McElvaney, P. Birrer, S. Shak, W. W. Robinson, C. Jolley, M. Wu, 
M. S. Chemick, and R. G. Crystal. 1992. A preliminary study of aerosolized recombinant 
human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl. J Med 326:812- 
815. 
15. McElvaney, N. G., R. C. Hubbard, P. Birrer, M. S. Chemick, D. B. Caplan, M. M. Frank, 
and R. G. Crystal. 1991. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 
337:392-394. 
16. Boucher, R. C. 1992. Drug Therapy in the 1990's: What Can We Expect for Cystic 
Fibrosis? Drugs 43:431-439. 
17. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankaskas, P. Gilligan, M. King, L. 
J. Edwards, R. W. Helms, and R. C. Boucher. 1990. A pilot study of aerosolized 
amiloride for the treatment of lung disease in cystic fibrosis. N Engl. J Med 322:1189- 
1194. 
18. App, E. M., M. King, R. Helfesrieder, D. Kohler, and H. Matthys. 1990. Acute and long- 
term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic 
fibrosis therapy. Am Rev Respir Dis 141:605-612. 
19. Knowles, M. R., L. L. Clarke, and R. C. Boucher. 1991. Activation by extracellular 
nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N 
Engl J Med 325:533-538. 
20. Ames, G. F., C. S. Mimura, and V. Shyamala. 1990. Bacterial periplasmic permeases 
belong to a family of transport proteins operating from Escherichia coli to human: Traffic 
ATPases. FEMS. Microbiol. Rev 6:429-446. 
21. Hyde, S. C., P. Emsley, M. J. Hartshorn, M. M. Mimmack, U. Gileadi, S. R. Pearce, M. 
P. Gallagher, D. R. Gill, R. E. Hubbard, and C. F. Higgins. 1990. Structural model of 
ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial 
transport. Nature 346:362-365. 
22. Gregory, R. J., S. H. Cheng, D. P. Rich, J. Marshall, S. Paul, K. Hehir, L. Ostedgaard, K. 
W. Klinger, M. J. Welsh, and A. E. Smith. 1990. Expression and characterization of the 
cystic fibrosis transmembrane conductance regulator. Nature 347:382-386. 
23. Drumm, M. L., H. A. Pope, W. H. Cliff, J. M. Rommens, S. A. Marvin, L-C. Tsui, F. S. 
Collins, R. A. Frizzell, and J. M. Wilson. 1990. Correction of the cystic fibrosis defect in 
vitro by retrovirus-mediated gene transfer. Cell 62:1227-1233. 
24. Denning, G. M., L. S. Ostedgaard, S. H. Cheng, A. E. Smith, and M. J. Welsh. 1992. 
Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory 
epithelia. J Clin Invest 89:339-349. 
25. Kartner, N., J. W. Hanrahan, T. J. Jensen, A. L. Naismith, S. Sun, C. A. Ackerley, E. F. 
Reyes, L-C. Tsui, J. M. Rommens, C. E. Bear, and J. R. Riordan. 1991. Expression of the 
cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion 
conductance. Cell 64:681-691. 
26. Crawford, I., P. C. Maloney, P. L. Zeitlin, W. B. Guggino, S. C. Hyde, H. Turley, K. C. 
Gatter, A. Harris, and C. F. Higgins. 1991. Immunocytochemical localization of the 
cystic fibrosis gene product CFTR. Proc Natl Acad Sci. U. S. A. 88:9262-9266. 
[926] 
Recombinant DNA Research, Volume 16 
